Read the latest and past features

We're excited to share PAPAA's brand-new Issue 62 of Skin 'n' Bones Connection our go-to biannual journal full of trusted, evidence-based information.

As the nights draw in and the days get colder, many of us start to feel the impact, physically and emotionally.

Imaging tests such as X-rays, MRIs, and CT scans remain essential for diagnosing and managing psoriatic disease.

A major international study has examined how many people develop psoriasis worldwide and how this is likely to change over time.

As part of the BBC’s Scam Safe Week (22–28 November 2025), we’re sharing an important reminder for anyone living with long-term health conditions.

The International Psoriasis Council (IPC) has published an important systematic review on the way in which psoriasis affects children and their families.

Psoriasis is fundamentally an inflammatory disease which manifests itself in skin, joints and other body organs. There is a well-described link between psoriasis and cardiovascular disease, but the mechanism which connects skin inflammation to the cardiovascular system has, until now, been poorly understood.

People living with more severe psoriasis are at a greater risk of developing psoriatic arthritis (PsA), an inflammatory condition that affects the joints. Understanding this connection is important, as early and effective treatment for psoriasis may help reduce the risk of PsA.

Today, Wednesday, 29 October,  marks World Psoriasis Day 2025, where millions of people across the globe unite in recognition of the challenges faced by those living with psoriasis and psoriatic arthritis. As the official UK member of IFPA, we support this year's theme: "Psoriatic Disease and Comorbidities – Understanding the Domino Effect."​

Historically, most of the approaches to treating psoriasis have focused on inhibiting the actions of pro-inflammatory immune cells, i.e. the cells causing the inflammatory response.